2-[3,5-Bis-(2-fluorobenzylidene)-4-piperidon-1-yl]-N-(4-fluorobenzyl)-acetamide and Its Evaluation as an Anticancer Agent
Figure 5
The dynamic clearance data obtained by drawing regions of interest around heart, liver, and kidney in reconstructed PET images. Heart-bound radioactivity may be partially indicative of NFLOBA-EF24 circulating in blood. The time-specific PET images in inset (a) show visual clearance of labeled drug from the body with respect to time.
